Wugen

Phase 1/2

St. Louis, United StatesFounded 2018wugen.com

Oncology Evolved Engineering the Next Generation of Off-the-Shelf Cell Therapies learn about WU-CART PIPELINE learn more PRE-CLINICAL CLINICAL CAR-T (Allogeneic) T-ALL/LBL T-NHL AML Autoimmune LATEST NEWS learn more Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007 Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable...

Founded

2018

Focus

Cell & Gene Therapy

About

Oncology Evolved Engineering the Next Generation of Off-the-Shelf Cell Therapies learn about WU-CART PIPELINE learn more PRE-CLINICAL CLINICAL CAR-T (Allogeneic) T-ALL/LBL T-NHL AML Autoimmune LATEST NEWS learn more Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007 Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable...

Company Info

TypePrivate

Founded2018

LocationSt. Louis, United States

StagePhase 1/2

Contact

Sectors

Cell & Gene Therapy Oncology (General)

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.